LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 33

Search options

  1. Article: Vitamin E supplementation improves high-densitiy lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis
.

    Mune, Masatoshi / Uto-Kondo, Harumi / Iteya, Iwao / Fujii, Yoshiyuki / Ikeda, Saiko / Ikewaki, Katsunori

    Clinical nephrology

    2018  Volume 90, Issue 3, Page(s) 212–221

    Abstract: Background and aims: Patients with end-stage kidney disease (ESKD) undergoing hemodialysis (HD) have been shown to be at increased risk for cardiovascular disease (CVD). Decreased high-density lipoprotein cholesterol (HDL-C) and impaired cholesterol ... ...

    Abstract Background and aims: Patients with end-stage kidney disease (ESKD) undergoing hemodialysis (HD) have been shown to be at increased risk for cardiovascular disease (CVD). Decreased high-density lipoprotein cholesterol (HDL-C) and impaired cholesterol efflux capacity (CEC) have been reported in such patients, and effects of vitamin E supplementation on HDL functions are poorly understood. Therefore, the present study aimed to investigate effects of vitamin E supplementation on HDL and endothelial functions in ESKD patients undergoing HD. We also assessed the influence of diabetes and haptoglobin (Hp) phenotype on the effects of vitamin E.
    Materials and methods: Vitamin E (300 mg daily) was supplemented for 12 weeks, followed by a 10-week washout phase in 40 ESKD patients undergoing HD (20 diabetic and 20 nondiabetic patients). HDL functions, including CEC, antioxidant capacity, and anti-inflammatory activity, were investigated. In diabetic patients, endothelial function, as represented by flow-mediated vasodilatation (FMD), was also assessed. The findings were compared according to diabetic condition or Hp phenotype.
    Results: Vitamin E significantly increased CEC, whereas antioxidant capacity and anti-inflammatory activity remained unchanged. Further, the improvement in CEC was maintained after the 10-week washout phase. Endothelial function was significantly improved in diabetic patients. Subanalyses based on diabetes or Hp phenotype revealed that neither diabetes nor Hp phenotype influenced the effects of vitamin E.
    Conclusion: In ESKD patients undergoing hemodialysis, vitamin E supplementation significantly improved the HDL function of CEC and, in diabetic patients, endothelial function. These effects were independent of Hp phenotype.
.
    MeSH term(s) Adult ; Aged ; Antioxidants/pharmacology ; Dietary Supplements ; Dyslipidemias/blood ; Dyslipidemias/drug therapy ; Dyslipidemias/etiology ; Female ; Humans ; Kidney Failure, Chronic/complications ; Kidney Failure, Chronic/physiopathology ; Kidney Failure, Chronic/therapy ; Lipoproteins, HDL/metabolism ; Male ; Middle Aged ; Renal Dialysis ; Vitamin E/pharmacology ; Young Adult
    Chemical Substances Antioxidants ; Lipoproteins, HDL ; Vitamin E (1406-18-4)
    Language English
    Publishing date 2018-04-20
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 185101-9
    ISSN 0301-0430
    ISSN 0301-0430
    DOI 10.5414/CN109197
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Atherosclerosis and vascular calcification in hemodialysis patients].

    Hirasaka, Naohisa / Liang, Xiang-Ming / Mune, Masatoshi

    Clinical calcium

    2004  Volume 14, Issue 6, Page(s) 85–90

    Abstract: Cardiovascular disease is the largest cause of mortality in hemodialysis patients. Cardiovascular mortality is fivefold to twentyfold higher in hemodialysis patients than in the general population. Atherosclerosis and vascular calcification are the ... ...

    Abstract Cardiovascular disease is the largest cause of mortality in hemodialysis patients. Cardiovascular mortality is fivefold to twentyfold higher in hemodialysis patients than in the general population. Atherosclerosis and vascular calcification are the characteristic complications in hemodialysis patients. Hemodialysis patients have traditional risk factors such as abnormal lipid metabolism and uremia-related risk factors such as oxidative stress and hyperphosphatemia. Oxidative stress takes place by increased production of oxidants by leukocytes and antioxidant loss of vitamin C and E. Oxidatively modified LDL exist in the circulation by excess of oxidative stress in hemodialysis patients. Oxidative stress is a major contributor to accelerated development atherosclerosis. Oxidative stress and hyperphosphatemia also influence vascular calcification. The pattern of vascular calcification in hemodialysis patient is characterized by mineral deposition in the tunica media. It is reported that the obvious calcification in aorta and artery of the MGP knockout mouse is recognized. It is indicated that MGP has the inhibitory effect of the calcification of vessel wall. Vitamin E protects atherosclerosis and vascular calcification in hemodialysis patients. It is also important to control hyperphosphatemia for vascular calcification.
    MeSH term(s) Animals ; Arteriosclerosis/etiology ; Arteriosclerosis/prevention & control ; Calcinosis/etiology ; Calcinosis/prevention & control ; Calcium-Binding Proteins/physiology ; Calcium-Binding Proteins/therapeutic use ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/prevention & control ; Cause of Death ; Extracellular Matrix Proteins/physiology ; Extracellular Matrix Proteins/therapeutic use ; Humans ; Lipid Metabolism ; Metabolic Diseases/complications ; Mice ; Oxidative Stress/physiology ; Phosphorus/blood ; Phosphorus Metabolism Disorders/complications ; Renal Dialysis/adverse effects ; Renal Dialysis/mortality ; Risk Factors ; Uremia/complications ; Vitamin E/therapeutic use ; Matrix Gla Protein
    Chemical Substances Calcium-Binding Proteins ; Extracellular Matrix Proteins ; Vitamin E (1406-18-4) ; Phosphorus (27YLU75U4W)
    Language Japanese
    Publishing date 2004-12-02
    Publishing country Japan
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2386417-5
    ISSN 0917-5857
    ISSN 0917-5857
    DOI CliCa0406931936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function.

    Muso, Eri / Sakai, Soichi / Ogura, Youske / Yukawa, Susumu / Nishizawa, Yoshiki / Yorioka, Noriaki / Saito, Takao / Mune, Masatoshi / Sugiyama, Satoshi / Iino, Yasuhiko / Hirano, Tsutomu / Hattori, Motoshi / Watanabe, Tsuyoshi / Yokoyama, Hitoshi / Sato, Hiroshi / Uchida, Shunya / Wada, Takashi / Shoji, Tetsuo / Oda, Hiroaki /
    Mori, Kiyoshi / Kimura, Hideki / Ito, Osamu / Nishiyama, Akira / Maruyama, Shoichi / Inagi, Reiko / Fujimoto, Shoichi / Tsukamoto, Tatsuo / Suzuki, Yusuke / Honda, Hirokazu / Babazono, Tetsuya / Tsuruya, Kazuhiko / Yuzawa, Yukio

    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

    2021  Volume 26, Issue 1, Page(s) 220–228

    Abstract: Many reports have shown the therapeutic efficacy of LDL apheresis (LDL-A) in drug-resistant nephrotic syndrome (NS) for improvement of heavy proteinuria and severely impaired renal function. To obtain comprehensive results in a large number of cases, a ... ...

    Abstract Many reports have shown the therapeutic efficacy of LDL apheresis (LDL-A) in drug-resistant nephrotic syndrome (NS) for improvement of heavy proteinuria and severely impaired renal function. To obtain comprehensive results in a large number of cases, a post hoc analysis of the Prospective Observational survey on the Long-Term Effects of the LDL-Apheresis on the Drug Resistant Nephrotic Syndrome (POLARIS) study was performed by stratifying enrolled cases according to the pretreatment estimated glomerular filtration rate (eGFR) levels indicating normal (N) (≥60 ml/min/1.73 m
    MeSH term(s) Blood Component Removal/methods ; Cohort Studies ; Humans ; Lipoproteins, LDL/blood ; Nephrotic Syndrome/blood ; Nephrotic Syndrome/complications ; Nephrotic Syndrome/therapy ; Prospective Studies ; Renal Insufficiency/blood ; Renal Insufficiency/complications ; Renal Insufficiency/therapy ; Treatment Outcome
    Chemical Substances Lipoproteins, LDL
    Language English
    Publishing date 2021-06-21
    Publishing country Australia
    Document type Journal Article ; Multicenter Study ; Observational Study
    ZDB-ID 2119809-3
    ISSN 1744-9987 ; 1091-6660 ; 1744-9979
    ISSN (online) 1744-9987
    ISSN 1091-6660 ; 1744-9979
    DOI 10.1111/1744-9987.13694
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Effects of antioxidants on kidney disease.

    Mune, Masatoshi / Otani, Haruhisa / Yukawa, Susumu

    Mechanisms of ageing and development

    2001  Volume 123, Issue 8, Page(s) 1041–1046

    Abstract: Kidney mesangial cells (MCs) and vascular smooth muscle cells (VSMCs) are closely related in terms of origin, microscopic anatomy, histochemistry, and contractility. This relationship suggests a similarity between kidney glomerular sclerosis and ... ...

    Abstract Kidney mesangial cells (MCs) and vascular smooth muscle cells (VSMCs) are closely related in terms of origin, microscopic anatomy, histochemistry, and contractility. This relationship suggests a similarity between kidney glomerular sclerosis and atherosclerosis. Vitamin E appears beneficial in the prevention and treatment of coronary disease and also inhibits the proliferation of VSMCs in vitro. We used vitamin E and probucol to treat glomerular sclerosis and MC-proliferative glomerulonephritis (GN) in two animal models of glomerular disease. Using rats, a remnant kidney model accelerated with hyperlipidemia was employed to reflect progressive glomerular sclerosis leading to chronic renal failure, and an anti-thymocyte serum treatment was used to model acute MC-proliferative GN. Supplemental dietary antioxidants suppress MC proliferation and glomerular sclerosis in models of glomerular disease in rats. These results suggest that treatment with antioxidants may be a promising intervention to prevent progression of kidney disease.
    MeSH term(s) Animals ; Antioxidants/therapeutic use ; Cholesterol, Dietary/adverse effects ; Dietary Supplements ; Disease Models, Animal ; Glomerulonephritis, Membranoproliferative/chemically induced ; Glomerulonephritis, Membranoproliferative/drug therapy ; Glomerulonephritis, Membranoproliferative/metabolism ; Glomerulonephritis, Membranoproliferative/physiopathology ; Glomerulosclerosis, Focal Segmental/chemically induced ; Glomerulosclerosis, Focal Segmental/drug therapy ; Glomerulosclerosis, Focal Segmental/immunology ; Glomerulosclerosis, Focal Segmental/metabolism ; Kidney Cortex/metabolism ; Macrophages/cytology ; Male ; Rats ; Rats, Inbred BN ; Rats, Inbred F344 ; Rats, Sprague-Dawley ; Thy-1 Antigens/immunology ; Vitamin E/therapeutic use
    Chemical Substances Antioxidants ; Cholesterol, Dietary ; Thy-1 Antigens ; Vitamin E (1406-18-4)
    Language English
    Publishing date 2001-02-23
    Publishing country Ireland
    Document type Journal Article
    ZDB-ID 183915-9
    ISSN 1872-6216 ; 0047-6374
    ISSN (online) 1872-6216
    ISSN 0047-6374
    DOI 10.1016/s0047-6374(01)00387-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Effects of a Long-Term High-Fat Diet and Switching from a High-Fat to Low-Fat, Standard Diet on Hepatic Fat Accumulation in Sprague-Dawley Rats

    Omagari, Katsuhisa / Kato, Shigeko / Tsuneyama, Koichi / Inohara, Chisato / Kuroda, Yu / Tsukuda, Hiroe / Fukazawa, Eri / Shiraishi, Keiko / Mune, Masatoshi

    Digestive diseases and sciences. 2008 Dec., v. 53, no. 12

    2008  

    Abstract: To investigate the effects of a long-term high-fat diet and switching from high-fat to a low-fat diet on hepatic fat accumulation in Sprague-Dawley (SD) rats, 3-week-old male SD rats were fed a high-fat diet (HFD) containing 45% fat (kilocalories) for 43 ...

    Abstract To investigate the effects of a long-term high-fat diet and switching from high-fat to a low-fat diet on hepatic fat accumulation in Sprague-Dawley (SD) rats, 3-week-old male SD rats were fed a high-fat diet (HFD) containing 45% fat (kilocalories) for 43 weeks (HDHD group), an HFD for 23 weeks followed by a low-fat, standard diet (LFD) containing 10% fat for 20 weeks (HDLD group), and an LFD for 43 weeks (LDLD group). Histopathologically, steatosis and lobular inflammation was obvious in the HDLD and HDHD groups at 46 weeks of age, and ballooning hepatocytes and Mallory hyalines were seen in the HDHD group. Mild fibrosis was observed in 5 of 13 (38%) rats in the HDHD or HDLD groups. Our results demonstrate that a long-term high-fat diet can induce nonalcoholic steatohepatitis (NASH) in SD rats. Switching to a low-fat, standard diet prevented the progression of NASH, although steatosis was not improved.
    Language English
    Dates of publication 2008-12
    Size p. 3206-3212.
    Publisher Springer US
    Publishing place Boston
    Document type Article
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-008-0303-1
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: The efficacy of vitamin E against oxidative damage and autoantibody production in systemic lupus erythematosus: a preliminary study.

    Maeshima, Etsuko / Liang, Xiang-Ming / Goda, Mikako / Otani, Haruhisa / Mune, Masatoshi

    Clinical rheumatology

    2007  Volume 26, Issue 3, Page(s) 401–404

    Abstract: The hypothesis that reactive oxygen species (ROS) modification of DNA is involved in the development of autoantibodies in systemic lupus erythematosus (SLE) is supported by the enhanced reactivity of anti-DNA antibodies to ROS-denatured DNA. We studied ... ...

    Abstract The hypothesis that reactive oxygen species (ROS) modification of DNA is involved in the development of autoantibodies in systemic lupus erythematosus (SLE) is supported by the enhanced reactivity of anti-DNA antibodies to ROS-denatured DNA. We studied the efficacy of vitamin E against both oxidative DNA damage and autoantibody production in SLE. Urinary 8-hydroxydeoxyguanosine (8-OHdG), an indicator of oxidative DNA damage, and the anti-double-stranded DNA (anti-ds DNA) antibody, a predictor of disease activity, were assayed twice, first during the season with the most intense sunlight and then later in the year. Twelve women among 36 outpatients received vitamin E (150 to 300 mg/day) together with prednisolone (PSL). No significant age or daily dose of PSL differences were evident between patient groups. Urinary 8-OHdG in the PSL with vitamin E group (15.0 +/- 10.2 ng/mg during the period of intense sunlight and 11.7 +/- 8.7 ng/mg during the remainder of the year) did not differ significantly from that in the PSL without vitamin E group (20.0 +/- 23.2 and 11.0 +/- 5.9 ng/mg, at these respective times), but the anti-ds DNA antibody titer in the PSL with vitamin E group (17.9 +/- 20.3 IU/l during the period of intense sunlight and 16.3 +/- 19.4 IU/l during the remainder of the year) was significantly lower than that in the PSL without vitamin E group for both sunlight-defined periods (66.3 +/- 76.8 and 55.8 +/- 59.0 IU/l, at these respective times; P < 0.05). The present study suggests that vitamin E can suppress autoantibody production via a mechanism independent of antioxidant activity.
    MeSH term(s) Adult ; Antioxidants/therapeutic use ; Autoantibodies/drug effects ; DNA Damage ; Female ; Humans ; Lupus Erythematosus, Systemic/drug therapy ; Lupus Erythematosus, Systemic/immunology ; Middle Aged ; Oxidative Stress ; Pilot Projects ; Reactive Oxygen Species ; Seasons ; Sunlight/adverse effects ; Vitamin E/therapeutic use
    Chemical Substances Antioxidants ; Autoantibodies ; Reactive Oxygen Species ; Vitamin E (1406-18-4)
    Language English
    Publishing date 2007-03
    Publishing country Germany
    Document type Clinical Trial ; Journal Article
    ZDB-ID 604755-5
    ISSN 0770-3198
    ISSN 0770-3198
    DOI 10.1007/s10067-006-0477-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion.

    Maeshima, Etsuko / Nishimoto, Takeshi / Yamashita, Mikako / Mune, Masatoshi / Yukawa, Susumu

    Rheumatology international

    2003  Volume 23, Issue 5, Page(s) 252–254

    Abstract: Pleural fluid rarely occurs in patients with progressive systemic sclerosis (PSS) or polymyositis (PM) with no lesions in the pulmonary area. Pleural fluids in patients with autoimmune diseases are mostly dominated by monocytes and lymphocytes but very ... ...

    Abstract Pleural fluid rarely occurs in patients with progressive systemic sclerosis (PSS) or polymyositis (PM) with no lesions in the pulmonary area. Pleural fluids in patients with autoimmune diseases are mostly dominated by monocytes and lymphocytes but very rarely contain increased eosinophils. We report a 55-year-old male with PSS-PM overlap syndrome and eosinophilic pleural effusion. Air invasion into the pleural cavity and the antituberculous therapy could be ruled out as causes for the patient's eosinophilic pleural effusion, because the differential eosinophil count was already as high as 19% from the first thoracentesis before the start of antituberculous therapy. Infections and malignant tumor also were unlikely causes based upon the negative pleural fluid results and the negative pleural biopsy findings, except for nonspecific inflammation. After the administration of corticosteroid, the pleural effusion decreased promptly, with normalization of serum creatine phosphokinase and C-reactive protein concentrations.
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; C-Reactive Protein/analysis ; Creatine Kinase/blood ; Eosinophilia/drug therapy ; Eosinophilia/etiology ; Eosinophilia/immunology ; Humans ; Male ; Middle Aged ; Pleural Effusion/drug therapy ; Pleural Effusion/etiology ; Pleural Effusion/immunology ; Polymyositis/blood ; Polymyositis/complications ; Polymyositis/drug therapy ; Polymyositis/immunology ; Prednisolone/therapeutic use ; Scleroderma, Diffuse/blood ; Scleroderma, Diffuse/complications ; Scleroderma, Diffuse/drug therapy ; Scleroderma, Diffuse/immunology ; Treatment Outcome
    Chemical Substances Anti-Inflammatory Agents ; C-Reactive Protein (9007-41-4) ; Prednisolone (9PHQ9Y1OLM) ; Creatine Kinase (EC 2.7.3.2)
    Language English
    Publishing date 2003-09
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 8286-7
    ISSN 1437-160X ; 0172-8172
    ISSN (online) 1437-160X
    ISSN 0172-8172
    DOI 10.1007/s00296-003-0297-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Effects of a long-term high-fat diet and switching from a high-fat to low-fat, standard diet on hepatic fat accumulation in Sprague-Dawley rats.

    Omagari, Katsuhisa / Kato, Shigeko / Tsuneyama, Koichi / Inohara, Chisato / Kuroda, Yu / Tsukuda, Hiroe / Fukazawa, Eri / Shiraishi, Keiko / Mune, Masatoshi

    Digestive diseases and sciences

    2008  Volume 53, Issue 12, Page(s) 3206–3212

    Abstract: To investigate the effects of a long-term high-fat diet and switching from high-fat to a low-fat diet on hepatic fat accumulation in Sprague-Dawley (SD) rats, 3-week-old male SD rats were fed a high-fat diet (HFD) containing 45% fat (kilocalories) for 43 ...

    Abstract To investigate the effects of a long-term high-fat diet and switching from high-fat to a low-fat diet on hepatic fat accumulation in Sprague-Dawley (SD) rats, 3-week-old male SD rats were fed a high-fat diet (HFD) containing 45% fat (kilocalories) for 43 weeks (HDHD group), an HFD for 23 weeks followed by a low-fat, standard diet (LFD) containing 10% fat for 20 weeks (HDLD group), and an LFD for 43 weeks (LDLD group). Histopathologically, steatosis and lobular inflammation was obvious in the HDLD and HDHD groups at 46 weeks of age, and ballooning hepatocytes and Mallory hyalines were seen in the HDHD group. Mild fibrosis was observed in 5 of 13 (38%) rats in the HDHD or HDLD groups. Our results demonstrate that a long-term high-fat diet can induce nonalcoholic steatohepatitis (NASH) in SD rats. Switching to a low-fat, standard diet prevented the progression of NASH, although steatosis was not improved.
    MeSH term(s) Adipose Tissue/metabolism ; Animals ; Blood Pressure/drug effects ; Body Fat Distribution ; Body Weight/drug effects ; Diet, Fat-Restricted ; Dietary Fats/pharmacology ; Disease Models, Animal ; Disease Progression ; Fatty Liver/metabolism ; Fatty Liver/pathology ; Hepatocytes/drug effects ; Hepatocytes/metabolism ; Hepatocytes/pathology ; Hyalin/metabolism ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis/metabolism ; Liver Cirrhosis/pathology ; Male ; Proteins/metabolism ; Rats ; Rats, Sprague-Dawley ; Time Factors
    Chemical Substances Dietary Fats ; Mallory body protein, human ; Proteins
    Language English
    Publishing date 2008-05-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 304250-9
    ISSN 1573-2568 ; 0163-2116
    ISSN (online) 1573-2568
    ISSN 0163-2116
    DOI 10.1007/s10620-008-0303-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: A possible rat model for non-alcoholic steatohepatitis: Histological findings in SHR/NDmcr-cp rats.

    Kato, Shigeko / Omagari, Katsuhisa / Tsuneyama, Koichi / Fukazawa, Eri / Tsukuda, Hiroe / Inohara, Chisato / Kuroda, Yu / Shiraishi, Keiko / Mune, Masatoshi

    Hepatology research : the official journal of the Japan Society of Hepatology

    2008  Volume 38, Issue 7, Page(s) 743–744

    Language English
    Publishing date 2008-03-25
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1387041-5
    ISSN 1386-6346 ; 0928-4346
    ISSN 1386-6346 ; 0928-4346
    DOI 10.1111/j.1872-034X.2008.00342.x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: [A case of pulmonary actinomycosis with recurrent hemoptysis].

    Nishimoto, Takeshi / Sasaki, Rie / Nakanishi, Hirotaka / Yamagata, Toshiyuki / Minakata, Yoshiaki / Mune, Masatoshi / Yukawa, Susumu

    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society

    2003  Volume 41, Issue 3, Page(s) 181–185

    Abstract: A 68-year-old man was admitted to our hospital because of hemoptysis in September 1999. Chest CT scans showed a nodular shadow with infiltration in the right S 7. Bronchial arteriography showed vascularization in the right S 7, and bronchial artery ... ...

    Abstract A 68-year-old man was admitted to our hospital because of hemoptysis in September 1999. Chest CT scans showed a nodular shadow with infiltration in the right S 7. Bronchial arteriography showed vascularization in the right S 7, and bronchial artery embolization was performed. However, in April and October 2000 hemoptysis recurred, and bronchial arteriography showed recurrence of vascularization in the same area, so embolization was performed again. Then, the patient was admitted in March 2001 because of recurrent hemoptysis. CT scans showed growth of the nodular shadow. Right lower lobectomy was performed, and the microscopic findings in the tissue from the resected lobe showed branching filamentous bacteria, and pulmonary actinomycosis was diagnosed. We concluded that pulmonary actinomycosis should be considered in the differential diagnosis of nodular shadows with recurrent hemoptysis.
    MeSH term(s) Actinomycosis/complications ; Actinomycosis/diagnosis ; Actinomycosis/pathology ; Actinomycosis/therapy ; Aged ; Bronchial Arteries ; Diagnosis, Differential ; Embolization, Therapeutic/methods ; Hemoptysis/etiology ; Hemoptysis/therapy ; Humans ; Lung Diseases/complications ; Lung Diseases/diagnosis ; Lung Diseases/pathology ; Lung Diseases/therapy ; Male ; Pneumonectomy ; Recurrence ; Tomography, X-Ray Computed
    Language Japanese
    Publishing date 2003-03
    Publishing country Japan
    Document type Case Reports ; English Abstract ; Journal Article
    ZDB-ID 1456536-5
    ISSN 1345-9538 ; 1343-3490
    ISSN (online) 1345-9538
    ISSN 1343-3490
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top